Dr. Daley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-919-2013Fax+1 617-730-0222
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1993 - 1994
- Massachusetts General HospitalResidency, Internal Medicine, 1991 - 1993
- Harvard Medical SchoolClass of 1991
Certifications & Licensure
- MA State Medical License 1993 - 2025
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2011
- Elected Member The American Society for Clinical Investigation, 2003
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Join now to see all
Publications & Presentations
PubMed
- Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cells.Sherry Li Zheng, Jonas L Fowler, Julie Y Chen, Christopher Li, Elaine Lin
STAR Protocols. 2025-03-21 - Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers.Mohamad Ali Najia, Deepak K Jha, Cheng Zhang, Benoit Laurent, Caroline Kubaczka
Biorxiv. 2025-02-05 - 1 citationsThe dynamics of hematopoiesis over the human lifespan.Hojun Li, Parker Côté, Michael Kuoch, Jideofor Ezike, Katie Frenis
Nature Methods. 2025-02-01
Journal Articles
- The Toughest Triage — Allocating Ventilators in a PandemicRobert D Truog, George Q Daley, The New England Journal of Medicine
- The Toughest Triage — Allocating Ventilators in a PandemicRobert D Truog, George Q Daley, The New England Journal of Medicine
Press Mentions
- Legendary Former NIH Director Retires from Embattled AgencyMarch 1st, 2025
- Harvard Medical School Gets $6M Gift for AI in Healthcare ProgramNovember 14th, 2024
- Making Ionocytes: A Step Toward Cell or Gene Therapy for Cystic FibrosisApril 21st, 2023
- Join now to see all
Grant Support
- Models to study the synergy between autoimmunity and metabolism in T1DUNIV OF MASSACHUSETTS MED SCH WORCESTER2025–2026
- Molecular Circuits in the Hematopoietic Stem Cell NicheBOSTON CHILDREN'S HOSPITAL2020–2025
- Molecular Circuits in the Hematopoietic Stem Cell NicheBOSTON CHILDREN'S HOSPITAL2020–2025
- Molecular Circuits in the Hematopoietic Stem Cell NicheBOSTON CHILDREN'S HOSPITAL2020–2025
- Stem cells for therapeutics discovery in genetic blood disordersBOSTON CHILDREN'S HOSPITAL2016–2025
- Customized Stem Cells For Clinical Application In Blood DisordersNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Human Pluripotent Stem Cell And Progenitor Models Of Cardiac And Blood DiseasesNational Heart, Lung, And Blood Institute2009–2011
- Novel Therapies For Fanconi AnemiaNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Second International Conference On Stem Cell EngineeringNational Heart, Lung, And Blood Institute2010
- Comparative Phenotypic, Functional, And Molecular Analysis Of ESC And IPSCNational Heart, Lung, And Blood Institute2009–2010
- Murine Models For Regenerative MedicineNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Hematopoietic Stem Cells From Pluripotent Embryonic Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- NIH Director'S Pioneer AwardOffice Of The Director, National Institutes Of Health2005–2008
- Therapeutic Mechanisms In Chronic Myelogenous LeukemiaNational Cancer Institute2004–2005
- Modeling Developmental Hematopoiesis With Embryonic StemNational Heart, Lung, And Blood Institute2003–2005
- NIH Director'S Pioneer Award (RMI)Office Of The Director, National Institutes Of Health2004
- Hematopoietic Stem Cells From Totipotent Stem Cell TypesNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
- Therapeutic Mechanisms In Chronic Myelogenous LeukemiaNational Cancer Institute2003
- Modeling Developmental Hematopoiesis With Embryonic StemNational Heart, Lung, And Blood Institute2002–2003
- Hematopoietic Stem Cells From Totipotent Stem Cell TypesNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
- Therapeutic Mechanisms In Chronic Myelogenous LeukemiaNational Cancer Institute2001–2003
- Molecular Pathways In Myeloproliferative DiseaseNational Cancer Institute1998–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: